Question 1

What is ETEPLIRSEN used for?

Accepted Answer

ETEPLIRSEN (brand name Exondys 51) is a Other indicated for See full prescribing information.

Question 2

How does ETEPLIRSEN work?

Accepted Answer

ETEPLIRSEN works through the following mechanism: 12.1 Mechanism of Action Eteplirsen is designed to bind to exon 51 of dystrophin pre-mRNA, resulting in exclusion of this exon during mRNA processing in patients with genetic mutations that are amenable to exon 51 skipping. Exon skipping is intended to allow for production of an internally truncated dystrophin protein, which was evaluated in Study 2 and Study 3 [ see Clinical Studies ( 14 ) ]..

Question 3

What are the most common side effects of ETEPLIRSEN?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ETEPLIRSEN. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ETEPLIRSEN the same as Exondys 51?

Accepted Answer

Exondys 51 is a brand name for ETEPLIRSEN. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ETEPLIRSEN

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations